Citius Pharmaceuticals Inc

Explore Citius Pharmaceuticals, a Nasdaq‑listed biopharma focused on anti‑infective, cancer‑adjunct and stem‑cell therapies, and its market dynamics, financials, and growth potential.

Citius Pharmaceuticals Inc. is a late-stage biopharmaceutical company focused on developing innovative therapies for adjunct cancer care, oncology, and stem cell therapy, despite facing financial and market challenges.

Citius Pharmaceuticals Inc is making strategic moves to bolster its market position and expand its product reach, despite facing market volatility, through initiatives such as a registered direct offering and a partnership with Cardinal Health.

Citius Pharmaceuticals Inc. is a biopharmaceutical company with a diverse pipeline of innovative therapies, positioning it as a key player in the healthcare sector despite recent market fluctuations.

Citius Pharmaceuticals Inc, a late-stage biopharmaceutical company, is navigating challenges and opportunities in the healthcare sector, with a diverse pipeline and strategic initiatives aimed at growth and recovery.